Weekly reads: odd FDA PRP warning, H3.3 & CTCF, Iowa AG gets $2.5M on stem cell clinic, Colossal Biosciences

by rss feed | May 24, 2026 | News Feeds, PRP kit, States, weekly reads

Platelet-rich plasma or PRP is a regenerative product that has grown in popularity. The literature on clinical applications of PRP is all over the place. Whether it works or not for any particular application is unclear to me. Many orthopedists seem enthused about it....

Weekly reads: FDA leadership purge goes beyond Marty Makary, rare gene therapy tumor, vaccines & dementia

by rss feed | May 17, 2026 | FDA purge, News Feeds, weekly reads

Marty Makary is officially out at the FDA. From STAT: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in. But there’s more going on here in what looks like an agency leadership purge. This is so crazy that it’s hard to...

Weekly reads: lab-grown sperm, stem cell pills, intranasal EVs, EMF Cell paper doubts, Makary toast?

by rss feed | May 10, 2026 | FDA, IVG, News Feeds, stem cell IVF, weekly reads

Have we reached the reproductive frontier of lab-grown sperm? Producing oocytes in the lab has always been thought to be the initial focus in this arena. It was thought that figuring out the way to maked lab-grown sperm would take longer. Now a new report suggests...

Weekly reads: Gene therapy for rare form of deafness free from Regeneron, OSK in the heart, real-time clinical trials

by rss feed | May 3, 2026 | deafness gene therapy, News Feeds, weekly reads

I’ve been trying to dig out from all the stuff that piled up while I was working toward a big grant deadline last week, catch up on recent news and papers, and during this time I was excited to see the news about an approved gene therapy for a rare form of...

Weekly reads: $1B+ Neurona acquisition, cells + organs = better transplant?, DAXX in germ cells, KRAS

by rss feed | Apr 26, 2026 | Neurona, News Feeds, stem cells for epilepsy, weekly reads

The last 3 weeks have been extremely busy with grant work, but one recent bit of news that caught my eye was UCB’s $1 billion+ acquisition of Neurona. Neurona has been on my radar screen for years. Neurona and stem cells for epilepsy Here’s the news: UCB...

Weekly reads: Prasad successor, Sammy Hagar stem cells, more on OSK trial, Finnish speaker needed

by rss feed | Apr 19, 2026 | FDA, News Feeds, Vinay Prasad, weekly reads

Vinay Prasad has only less than two  weeks left at the FDA atop CBER. I’ve been trying to imagine where CBER goes from here after he exits. It feels like FDA Commissioner Marty Makary and RFK Jr. will likely be the real leaders of CBER moving forward on key...